Medicare Advantage, prescription drug programs to remain stable for 2025
The Centers for Medicare & Medicaid Services Sept. 27 announced that average premiums, benefits and plan choices for Medicare Advantage and Part D will remain stable for 2025. Average premiums are projected to decline in both programs. For MA, the average monthly premium would decrease by $1.23 to $17, while the average total premium for a Part D prescription drug plan is expected to decrease by $7.45 to $46.50. Open enrollment for Medicare and Part D is from Oct. 15-Dec. 7.
Related News Articles
Headline
The AHA Sept. 17 urged the Department of Health and Human Services’ Office of Inspector General to further scrutinize policies and practices by certain…
Headline
The Centers for Medicare & Medicaid services Sept. 10 announced the opening of a 60-day public comment period regarding its proposed plan for new data…
Headline
Hospitals and health systems are seeing significant increases in administrative costs, including due to burdensome practices by commercial insurers that often…
Headline
The Centers for Medicare & Medicaid Aug. 15 announced it negotiated lower prices with drug makers for 10 high-cost, sole-source drugs, with the new prices…
Headline
More than 46 million prior authorization requests were submitted to Medicare Advantage insurers in 2022, according to KFF analysis released Aug. 6 examining…
Headline
The Centers for Medicare & Medicaid Services July 16 released its final guidance on the Medicare Prescription Payment Plan which will begin next year. The…